Premarket Mover: Neurobo Pharmaceuticals Inc (NRBO) Up 34.75%

Neurobo Pharmaceuticals Inc (NRBO) has gained Tuesday morning, with the stock adding 34.75% in pre-market trading to 3.8. NRBO's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 141 out of 146 industries, the stock ranks higher than 0% of stocks. Neurobo Pharmaceuticals Inc has fallen 13.76% over the past month, closing at $2.96 on June 22. During this period of time, the stock fell as low as $2.73 and as high as $3.46. NRBO has an average analyst recommendation of Strong Buy. The company has an average price target of $16.00.

NRBO has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on NRBO!

See Full NRBO Report

Neurobo Pharmaceuticals Inc has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 139 by this metric, NRBO ranks better than 9% of stocks.

Important Dates for Investors in NRBO:

-Neurobo Pharmaceuticals Inc is set to release earnings on 8/10/2021. During their last earnings release the company posted EPS of $-1.69. -We do not have a set dividend date for Neurobo Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Neurobo Pharmaceuticals Inc (NRBO)